2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt
2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt Basic information
- Product Name:
- 2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt
- Synonyms:
-
- 2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt
- 2H4]-Taurocholic Acid Sodium Salt
- Taurocholic acid-d4 (sodium)
- Sodium taurocholate-[D4
- TAUROCHOLICACID,SODIUMSALT(2,2,4,4-D4) IN METHANOL
- Ethanesulfonic acid, 2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-, sodium salt (1:1)
- D4-Taurocholic Acid Sodium Salt
- Taurocholic acid, sodium salt (2,2,4,4-D?, 98%) 100 μg/mL in methanol
- CAS:
- 2410279-93-3
- MF:
- C26H41D4NO7S.Na
- MW:
- 542.72
- Mol File:
- 2410279-93-3.mol
2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMF: 25 mg/mL,DMSO: 20 mg/mL,Ethanol: 2 mg/mL,PBS (pH 7.2): 3 mg/mL
- form
- A solid
- color
- White to off-white
- CAS Number Unlabeled
- 145-42-6
2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt Usage And Synthesis
Description
Taurocholic acid-d4 (TCA-d4) is intended for use as an internal standard for the quantification of TCA by GC- or LC-MS. TCA is a taurine-conjugated form of the primary bile acid cholic acid . Serum levels of TCA are decreased in patients with Crohn’s disease and those with ulcerative colitis with no extraintestinal manifestations, but are increased in patients with ulcerative colitis accompanied by hepatobiliary disease.
Uses
Taurocholic acid-d4 (sodium) is the deuterium labeled Taurocholic acid. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.
References
[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Mooranian A, et al. The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study. Drug Deliv Transl Res. 2015 Oct;5(5):511-22. DOI:10.1007/s13346-015-0248-9
2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsaltSupplier
- Tel
- 028-67271278 18628360895
- sales@artisbio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 18818260767
- sales@chemegen.com
- Tel
- 18501792038 18502138905
- shanpel@anpel.com.cn
- Tel
- 13540909846 13882008651
- 3848291069@qq.com